JP2017504590A5 - - Google Patents

Download PDF

Info

Publication number
JP2017504590A5
JP2017504590A5 JP2016538745A JP2016538745A JP2017504590A5 JP 2017504590 A5 JP2017504590 A5 JP 2017504590A5 JP 2016538745 A JP2016538745 A JP 2016538745A JP 2016538745 A JP2016538745 A JP 2016538745A JP 2017504590 A5 JP2017504590 A5 JP 2017504590A5
Authority
JP
Japan
Prior art keywords
composition
eudragit
item
linaclotide
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016538745A
Other languages
English (en)
Japanese (ja)
Other versions
JP6964380B2 (ja
JP2017504590A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/069838 external-priority patent/WO2015089326A1/en
Publication of JP2017504590A publication Critical patent/JP2017504590A/ja
Publication of JP2017504590A5 publication Critical patent/JP2017504590A5/ja
Priority to JP2021078445A priority Critical patent/JP7483656B2/ja
Application granted granted Critical
Publication of JP6964380B2 publication Critical patent/JP6964380B2/ja
Priority to JP2023115832A priority patent/JP2023126475A/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016538745A 2013-12-11 2014-12-11 リナクロチドの遅延放出組成物 Expired - Fee Related JP6964380B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021078445A JP7483656B2 (ja) 2013-12-11 2021-05-06 リナクロチドの遅延放出組成物
JP2023115832A JP2023126475A (ja) 2013-12-11 2023-07-14 リナクロチドの遅延放出組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361914951P 2013-12-11 2013-12-11
US201361914952P 2013-12-11 2013-12-11
US61/914,951 2013-12-11
US61/914,952 2013-12-11
PCT/US2014/069838 WO2015089326A1 (en) 2013-12-11 2014-12-11 Delayed release compositions of linaclotide

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2019029432A Division JP2019073559A (ja) 2013-12-11 2019-02-21 リナクロチドの遅延放出組成物
JP2021078445A Division JP7483656B2 (ja) 2013-12-11 2021-05-06 リナクロチドの遅延放出組成物

Publications (3)

Publication Number Publication Date
JP2017504590A JP2017504590A (ja) 2017-02-09
JP2017504590A5 true JP2017504590A5 (enExample) 2018-01-25
JP6964380B2 JP6964380B2 (ja) 2021-11-10

Family

ID=52293217

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016538745A Expired - Fee Related JP6964380B2 (ja) 2013-12-11 2014-12-11 リナクロチドの遅延放出組成物
JP2019029432A Pending JP2019073559A (ja) 2013-12-11 2019-02-21 リナクロチドの遅延放出組成物
JP2021078445A Active JP7483656B2 (ja) 2013-12-11 2021-05-06 リナクロチドの遅延放出組成物
JP2023115832A Pending JP2023126475A (ja) 2013-12-11 2023-07-14 リナクロチドの遅延放出組成物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019029432A Pending JP2019073559A (ja) 2013-12-11 2019-02-21 リナクロチドの遅延放出組成物
JP2021078445A Active JP7483656B2 (ja) 2013-12-11 2021-05-06 リナクロチドの遅延放出組成物
JP2023115832A Pending JP2023126475A (ja) 2013-12-11 2023-07-14 リナクロチドの遅延放出組成物

Country Status (29)

Country Link
US (7) US20160310560A1 (enExample)
EP (2) EP3079669B1 (enExample)
JP (4) JP6964380B2 (enExample)
KR (3) KR102509291B1 (enExample)
CN (3) CN112569199A (enExample)
AU (3) AU2014362220B2 (enExample)
CA (1) CA2933587C (enExample)
CL (1) CL2016001424A1 (enExample)
CY (1) CY1123953T1 (enExample)
DK (1) DK3079669T3 (enExample)
EA (1) EA201691216A1 (enExample)
EC (2) ECSP16059106A (enExample)
ES (1) ES2838007T3 (enExample)
HR (1) HRP20201753T1 (enExample)
HU (1) HUE052981T2 (enExample)
IL (2) IL246155A0 (enExample)
LT (1) LT3079669T (enExample)
MX (2) MX386584B (enExample)
NZ (2) NZ759512A (enExample)
PE (2) PE20211976A1 (enExample)
PH (1) PH12016501122B1 (enExample)
PL (1) PL3079669T3 (enExample)
PT (1) PT3079669T (enExample)
RS (1) RS61133B1 (enExample)
SG (2) SG11201604729QA (enExample)
SI (1) SI3079669T1 (enExample)
SM (1) SMT202000686T1 (enExample)
UA (1) UA119335C2 (enExample)
WO (2) WO2015089326A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA119335C2 (uk) * 2013-12-11 2019-06-10 Айронвуд Фармасьютикалз, Інк. Композиції лінаклотиду з затриманим вивільненням
WO2016020901A1 (en) 2014-08-07 2016-02-11 Acerta Pharma B.V. Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on btk occupancy and btk resynthesis rate
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
WO2016125064A1 (en) * 2015-02-02 2016-08-11 Aurobindo Pharma Ltd Stable compositions comprising linaclotide
JP2018516937A (ja) * 2015-06-05 2018-06-28 アイアンウッド ファーマシューティカルズ インコーポレイテッド リナクロチドの改変または標的放出製剤
US10588864B2 (en) 2016-03-11 2020-03-17 Gateway Pharmaceuticals LLC Pharmaceutical compositions for colon-specific delivery
WO2017156214A1 (en) * 2016-03-11 2017-09-14 Gateway Pharmaceutical LLC Pharmaceutical compositions for colon-specific delivery
US11534404B2 (en) * 2016-10-06 2022-12-27 Sucampo Ag Multilayer beads for pharmaceutical use
CN110475564A (zh) * 2016-12-21 2019-11-19 硬木药品公司 用利那洛肽的修饰的或延迟释放制剂治疗肠易激综合征的方法
KR102227486B1 (ko) * 2017-06-30 2021-03-12 롯데정밀화학 주식회사 프로톤 펌프 저해제를 포함하는 경구용 고형제제 조성물, 이를 포함하는 경구용 고형제제 및 그 제조방법
EA202092275A1 (ru) * 2018-03-23 2021-02-09 Палатин Текнолоджиз, Инк. Составы пептидов, специфичных к рецептору меланокортина, и способы доставки в желудочно-кишечный тракт
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
CN114206324A (zh) * 2019-06-10 2022-03-18 硬木药品公司 治疗与腹泻占主导的肠易激综合征相关的腹部疼痛
KR102104507B1 (ko) * 2019-08-23 2020-04-24 브릿지바이오테라퓨틱스(주) 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법
CN110935007B (zh) * 2019-12-12 2023-06-23 烟台大学 利那洛肽复方组合物、制剂及其用途和制备方法
GB202017863D0 (en) * 2020-11-12 2020-12-30 Intract Pharma Ltd Novel compositions
CN115105582A (zh) * 2021-03-17 2022-09-27 江苏豪森药业集团有限公司 一种含利那洛肽或其盐的药物组合物及其制备方法
WO2022245650A1 (en) * 2021-05-19 2022-11-24 Alberto Paz Orally administered compositions for cancer treatment
IL319961A (en) * 2022-10-03 2025-05-01 Brim Biotechnology Inc Preparations including PEDF-derived short peptides (PDSP) and their uses
TW202440065A (zh) * 2022-12-28 2024-10-16 日商中外製藥股份有限公司 包含分散對象物質的固體分散體、包含其之醫藥組合物及其製造方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7304036B2 (en) 2003-01-28 2007-12-04 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7371727B2 (en) 2003-01-28 2008-05-13 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
CN201252259Y (zh) * 2008-07-24 2009-06-03 富士康(昆山)电脑接插件有限公司 电连接器
RS60101B1 (sr) * 2008-08-15 2020-05-29 Ironwood Pharmaceuticals Inc Formulacije koje sadrže linaklotid za oralnu primenu
JP5964589B2 (ja) * 2008-12-03 2016-08-03 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcアゴニストの製剤およびその使用方法
US20130012454A1 (en) * 2009-07-06 2013-01-10 Ironwood Pharmaceuticals, Inc. Orally Disintegrating Compositions of Linaclotide
WO2011019819A1 (en) * 2009-08-12 2011-02-17 Forest Laboratories Holdings Limited Orally disintegrating compositions of linaclotide
US8748573B2 (en) * 2009-08-06 2014-06-10 Ironwood Pharmaceuticals, Inc. Formulations comprising linaclotide
RU2012109415A (ru) * 2009-08-13 2013-09-20 Айронвуд Фармасьютикалз, Инк. Способ модуляции фармакодинамического эффекта перорально вводимых агонистов рецептора гуанилатциклазы
CA2790213A1 (en) * 2010-02-17 2011-08-25 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
ES2763404T3 (es) * 2010-08-11 2020-05-28 Ironwood Pharmaceuticals Inc Formulaciones estables de linaclotida
US20140162963A1 (en) * 2010-09-11 2014-06-12 Forest Laboratories Holdings Limited Treatment of Constipation-Predominant Irritable Bowel Syndrome
JP2012155108A (ja) * 2011-01-26 2012-08-16 Kyocera Document Solutions Inc 現像ローラ、現像装置および画像形成装置
CN104053449B (zh) * 2011-08-17 2016-12-07 硬木药品公司 胃肠疾患的治疗
WO2013047795A1 (ja) * 2011-09-30 2013-04-04 アステラス製薬株式会社 粒子状医薬組成物
JP2016521249A (ja) * 2012-07-12 2016-07-21 フォレスト ラボラトリーズ ホールディングス リミテッド リナクロチド組成物
EP2958577A2 (en) * 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
UA119335C2 (uk) * 2013-12-11 2019-06-10 Айронвуд Фармасьютикалз, Інк. Композиції лінаклотиду з затриманим вивільненням

Similar Documents

Publication Publication Date Title
JP7483656B2 (ja) リナクロチドの遅延放出組成物
JP2014524444A5 (enExample)
CN105025888B (zh) 肠溶片
JP2022093472A (ja) リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法
US20230346878A1 (en) Treatment of Abdominal Pain Associated with Diarrhea-Predominant Irritable Bowel Syndrome
JP2018516937A5 (enExample)
HK40081509A (en) Delayed release compositions of linaclotide
HK40051190A (en) Delayed release compositions of linaclotide
HK40017265A (en) Methods of treating irritable bowel syndrome with modified or delayed release formulations of linaclotide
HK1237651A1 (en) Delayed release compositions of linaclotide